Glazer Capital LLC’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Glazer Capital LLC’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-950,858	Closed	-$9.52M	–	776
2022 Q3	$9.52M	Buy	950,858 +217,612	+30%	+$2.17M	0.17%	181
2022 Q2	$7.25M	Buy	733,246 +86,473	+13%	+$854K	0.18%	185
2022 Q1	$6.38M	Buy	646,773 +68,745	+12%	+$675K	0.18%	144
2021 Q4	$5.67M	Sell	578,028 -218,894	-27%	-$2.16M	0.14%	198
2021 Q3	$7.82M	Sell	796,922 -31,827	-4%	-$313K	0.14%	188
2021 Q2	$8.2M	Buy	828,749 +164,732	+25%	+$1.66M	0.13%	213
2021 Q1	$6.82M	Buy	+664,017	New	+$7.37M	0.1%	280

Glazer Capital LLC's LUXA Position: Q4 2022 in Review

Glazer Capital LLC sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 950,858 shares — an estimated $9.52M sold.

Glazer Capital LLC first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $9.52M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Glazer Capital LLC reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Glazer Capital LLC sold 950,858 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $9.52M.
Glazer Capital LLC first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
Glazer Capital LLC's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $9.52M in Q3 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Glazer Capital LLC's 13F filing for Q4 2022, filed 14 Feb 2023.